ArticleNeuropsychopharmacology : official publication of the American College of Neuropsychopharmacology2026
Modulation of the noradrenergic system using transcranial ultrasonic stimulation targeted to the brainstem locus coeruleus in awake mice.
Article in Neuropsychopharmacology : official publication of the American College of Neuropsychopharmacology, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
12 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Transcranial ultrasound stimulation (TUS) is a novel neuromodulation technique that can be used to non-invasively target the locus coeruleus (LC). The LC provides the majority of noradrenergic input to the brain and has been implicated in several neurological and psychiatric disorders. Before translation to human studies, establishing a dose-response relationship requires systematic characterization of two distinct effects: (1) the influence of stimulation protocol variations on norepinephrine (NE) release in LC target structures, and (2) the broader brain and bodily effects of LC-targeted TUS. We used fiber photometry to measure TUS-induced activation of LC neurons and release of NE in one of its major projection areas, the hippocampus. To evaluate widespread functional effects, we investigated changes in [
Identifiers
42850351What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.